IN VIVO ANTIBODIES FROM BIO X CELL
InVivoMAb anti-human CD133, clone CMab-43
Targeting CD133 to Investigate Cancer Stem Cells and Tumor Initiation
Cancer stem cells (CSCs) play a major role in tumor initiation, metastasis, and resistance to therapy. CD133 is a widely used CSC marker in glioblastoma, colon, liver, and pancreatic cancers, making it a critical target in tumorigenesis and xenograft studies.
InVivoMAb anti-human CD133, clone CMab-43, provides in vivo grade functional targeting of CD133-expressing cells to support cancer and translational research.
-Reliable and specific
-In vivo ready
-Proven in cancer modeling
Explore more on Bio X Cell’s InVivoMAb anti-human CD133, clone CMab-43.
All products listed on this site and sold through LAB-A-PORTER Limited are for research use only (RUO). Not for human use. Not for therapeutic or diagnostic use.
ABOUT BIO X CELL
Antibodies For In Vivo Research
Bio X Cell antibodies are formulated for in vivo experiments and used extensively in animal models of human disease. They feature greater than 95% purity, ultra-low endotoxin levels, and are presevative, stabilizer, and carrier protein-free. Bio X Cell has developed a wide range of antibodies for immuno-oncology, immunology, and neuroscience research. Their products are cited in over 15,000 publications that detail a broad range of applications, including in vivo cell-specific depletion, cytokine neutralization, immune checkpoint blockade, and more.
-
- Exceptional Purity
- Pathogen Free
- Ultra-low Endotoxin Level
- Advanced Binding Validation
- Low Protein Aggregation
- Marching Isotype Control Antibodies
All products listed on this site and sold through LAB-A-PORTER Limited are for research use only (RUO). Not for human use. Not for therapeutic or diagnostic use.